Medical Biomimetics Market Size, Share | Report 2022-2030
The global medical biomimetics market was valued at USD 32.6 billion in 2021 and it is predicted to surpass around USD 57.5 billion by 2030 with a CAGR of 6.51% from 2022 to 2030.
Biomimetics is the fastest developing area of bioengineering. It is the imitation of features found in plants and animals to provide both protection and treatment from illness and bacteria as well as disease management. Medical Biomimetics is considered a technology that uses or emulates nature for the improvement of the lives of humans. Biomimetics comprises principles from chemistry, engineering, and biology, applied to the synthesis of materials, machines, or synthetic systems that consist of functions or operations that mimic biological processes. Biomimetics-based designs are used in tissue engineering, regenerative medicine, and drug delivery. Medical biomimetics is witnessing promising anticipation in the making of surgical devices and instruments. These instruments perform the basic functions like cutting, stinging, and gripping which can be performed by hands, feet, mouth, and other organs.
There is an increasing demand for prostheses and implants for organ transplantation, which is a prominent factor to boost the biomimetics market. Some of the examples are electric eel-inspired power sources for artificial organs. Eel has the ability to produce shock up to 600 volts using concentrated cells. An electric synthetic organ producing 100 volts was built using the combination of hydrogels and salts which could be used to charge medical devices like pacemakers without external recharging. The product ‘Electric Eel’ is manufactured by ‘Electric Eel Manufacturing’ company based in Ohio, U.S. Some other examples are peacock inspires biosensors, gecko inspired surgical glue, octopus inspired sucker for tissue grafting. It is also used in the treatment of disease like Alzheimer’s. Intravenous neuronal tau targeting biomimetic nanoparticles for curcumin delivery is used for the cure of Alzheimer’s.
It is observed that the geriatric population are more prone for organ dysfunction and failure which will stimulate the increased use of biomimetics in devices and tools for organ recreation. This is expected to bring positive impact in the field of organ transplantation in the upcoming years. A rise in the application of medical biomimetics in noninvasive techniques including CT scans, ECGs, and ultrasound in the field of healthcare are projected to drive the growth in the market. The advancements in the field of Nanotechnology, leading to the improvement in drug delivery system will positively impact the market growth in the upcoming years. Recently, Nexa 3D, a 3D printer manufacturer announced a dental prosthetics material xMODEL 2505 for prosthetic use. Although stringent clinical and regulatory requirements could be the restraining factors. Also, Applied Biomimetic (confluent of polymer and protein membrane technologies) has announced inauguration of its new research facilities in Gaithersburg, Maryland., U.S.
The segments are based on product type and application. Some of the popular areas of application are dentistry, cardiology, orthopedics, ophthalmology. Based on application, market can be segmented into wound healing, plastic surgery, drug delivery, and tissue engineering. The drug delivery segment is anticipated to lead the market due to advancements in nanotechnology, which enable accurate and efficient non carrier drug delivery via biomimetic devices. Adequate funding and advancements in research and development will boost growth.
Based on regional analysis, the medical biomimetics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is a dominating market as the region has a high adoption rate of novel technology, growing geriatric population, rise in research and development activities associated with medical biomimetics, and key players. Asia Pacific is expected to expand at a high growth rate during the forecast period due to factors like an increase in patient population, government initiatives in the healthcare sectors, growth in the biotechnology sector.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 32.6 billion |
| Revenue Forecast by 2030 | USD 57.5 billion |
| Growth rate from 2022 to 2030 | CAGR of 6.51% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Type, Application, Region |
| Companies Covered |
BioHorizons IPH, Inc., Avinent, Biomimetics Technology Inc SynTouch Inc., Wright Medical Group N.V., Veryan Medical, Applied Biomimetic, Blatchford Group (Chas. A. Blatchford & Sons Ltd), and Abbott. |
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Biomimetics Market
5.1. COVID-19 Landscape: Medical Biomimetics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Biomimetics Market, By Type
8.1. Medical Biomimetics Market, by Type, 2022-2030
8.1.1. Cardiovascular
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Orthopedic
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Ophthalmology
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Dental
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Medical Biomimetics Market, By Application
9.1. Medical Biomimetics Market, by Application, 2022-2030
9.1.1. Wound healing
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Tissue Engineering
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Drug Delivery
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Plastic Surgery
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Medical Biomimetics Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
Chapter 11. Company Profiles
11.1. BioHorizons IPH, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Avinent
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Biomimetics Technology Inc SynTouch Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Wright Medical Group N.V.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Veryan Medical
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Applied Biomimetic
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Blatchford Group (Chas. A. Blatchford & Sons Ltd)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Abbott
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers